We are live on ! Find out more
DCP

Distillate Capital Partners Portfolio holdings

AUM $1.9B
1-Year Est. Return 2.22%
This Fund
S&P 500
This Quarter Est. Return
-1.16%
1 Year Est. Return
-2.22%
3 Year Est. Return
+17.78%
5 Year Est. Return
+50.1%
10 Year Est. Return
AUM
$376M
AUM Growth
+$16.1M
Cap. Flow
+$24.9M
Cap. Flow %
6.62%
Top 10 Hldgs %
20.86%
Holding
140
New
26
Increased
73
Reduced
11
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 23.47%
2 Healthcare 21.25%
3 Industrials 19.44%
4 Consumer Discretionary 12.31%
5 Consumer Staples 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
126
Lam Research
LRCX
$388B
-51,610
Closed -$3.36M
MCO icon
127
Moody's
MCO
$82B
-9,560
Closed -$3.46M
MU icon
128
Micron Technology
MU
$1.01T
-35,830
Closed -$3.04M
NDAQ icon
129
Nasdaq
NDAQ
$52.3B
-53,403
Closed -$3.13M
NTES icon
130
NetEase
NTES
$82.8B
-2,065
Closed -$238K
OTEX icon
131
Open Text
OTEX
$6.41B
-3,573
Closed -$182K
SSRM icon
132
SSR Mining
SSRM
$5.9B
-7,922
Closed -$124K
STZ icon
133
Constellation Brands
STZ
$22.7B
-12,309
Closed -$2.88M
TER icon
134
Teradyne
TER
$60.7B
-21,072
Closed -$2.82M
TMO icon
135
Thermo Fisher Scientific
TMO
$212B
-8,486
Closed -$4.28M
WB icon
136
Weibo
WB
$1.94B
-3,657
Closed -$192K
WPM icon
137
Wheaton Precious Metals
WPM
$56.5B
-4,139
Closed -$183K
XPO icon
138
XPO
XPO
$23.2B
-59,713
Closed -$2.89M
KL
139
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
-4,101
Closed -$158K
ALXN
140
DELISTED
Alexion Pharmaceuticals
ALXN
-19,518
Closed -$3.59M

Similar funds

Distillate Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Distillate Capital Partners held 140 positions worth $376M, up 4.5% from $360M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Distillate Capital Partners deployed $24.9M of net new capital in Q3 2021, opening 26 new positions and adding to 73 existing holdings. Its largest new stake was Elevance Health: 12,461 shares worth $4.64M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Bath & Body Works, an estimated $715K trimmed.

  • Distillate Capital Partners's largest Q3 2021 buy was Elevance Health: 12,461 shares worth $4.64M.
  • Distillate Capital Partners added most to Johnson & Johnson in Q3 2021, an estimated $2.55M increase.
  • Distillate Capital Partners's biggest Q3 2021 reduction was Bath & Body Works, cutting an estimated $715K.
  • Distillate Capital Partners fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $7.95M.
  • Distillate Capital Partners's ten largest holdings make up 21% of its $376M portfolio in Q3 2021.
  • Distillate Capital Partners opened 26 new positions and closed 30 in Q3 2021.
  • Distillate Capital Partners's portfolio value rose 4.5% quarter-over-quarter to $376M.

Based on Distillate Capital Partners's 13F filing for Q3 2021, filed 5 Nov 2021.